Precision medicine is at the heart of the future development of European healthcare. This is the indication of a roadmap presented by LifeTime ,the European consortium which sees HT amongs its associate partners.  The journal Nature published the article “LifeTime and improving European healthcare through cell-based interceptive medicine”. In the article innovators, research pioneers, clinicians, industry leaders and policy makers […]

Research and innovation are powerful drivers of a nation’s progress, both in terms of social progress, health and wellbeing of its citizens, and in terms of economic growth. One of the ties between research and innovation is the promotion of technology transfer, which is fundamental for translating research into development, spreading benefits and promoting economic growth. […]

Positions are open for Phd at the European School of Molecular Medicine (SEMM). As Human Technopole, we have 6 open positions available: 2 positions in Molecular Oncology in the Group of Prof. Vannini, Centre for Structural Biology. 2 positions in Molecular Oncology & Computational Biology in Prof. Testa’s Group, Neurogenomics Centre 1 position in Molecular […]

In a podcast by Nemesi, our President, Prof. Marco Simoni told about Human Technopole’s scientific projects, including those against Covid19 and explained how HT will be an open hub for both the scientific community and the industrial world. The podcast is available here: https://spoti.fi/39bV3gN

In these days we have finalised the agreement with the University of Naples Federico II that will allow the implementation of many synergies. In particular, the agreement allows for the exchange of research staff at all levels and the development of collaborative projects in areas of common interest. Moreover, the involvement in training activities and the […]